{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:35:12Z","timestamp":1794353712042,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014261","name":"National Institute for Health Care Management Foundation","doi-asserted-by":"publisher","award":["P01CA233452"],"award-info":[{"award-number":["P01CA233452"]}],"id":[{"id":"10.13039\/100014261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Colorectal liver metastasis (CRLM) occurs frequently in patients with colorectal cancer (CRC). Methionine adenosyltransferase (MAT) catalyzes the formation of S-adenosylmethionine, the principal methyl donor.\n                      <jats:italic>MAT1A<\/jats:italic>\n                      (encodes MAT\u03b11) is expressed mainly in normal adult liver, whereas\n                      <jats:italic>MAT2A<\/jats:italic>\n                      (encodes MAT\u03b12) is expressed in all extrahepatic tissues. MAT1A is a major defense against CRLM as loss of\n                      <jats:italic>Mat1a<\/jats:italic>\n                      sensitizes the liver to CRLM. In contrast, MAT2A is overexpressed in CRC and promotes oncogenicity. Here, we sought to determine if CRCs secrete MAT\u03b12 and if this influences CRLM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our study included human hepatocytes, human CRC cells, extracellular vesicle (EV) isolation, chromatin immunoprecipitation (ChIP), ChIP-seq, promoter activity assays, proliferation, migration, and invasion assays, western blotting, immunohistochemistry and immunofluorescence. We confirmed some of the findings using human hepatocyte spheroids, CRLM and normal liver tissue array, and plasma samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CRCs secrete MAT\u03b12 in free but truncated form (MAT\u03b12-t) and intact within EVs (EV-MAT\u03b12). EV-MAT\u03b12 can be internalized by human hepatocytes and CRCs, found within the nucleus, which then binds to\n                      <jats:italic>MAT1A<\/jats:italic>\n                      and\n                      <jats:italic>MAT2A<\/jats:italic>\n                      promoters on ChIP to lower and increase\n                      <jats:italic>MAT1A<\/jats:italic>\n                      and\n                      <jats:italic>MAT2A<\/jats:italic>\n                      promoter activities, respectively. In human CRLM samples, hepatocytes in nontumor regions express lower MAT\u03b11 but higher MAT\u03b12 as compared to normal liver. Treating RKO cells with EVs released from RKO cells overexpressing MAT2A promoted cell proliferation, migration, and invasion. MAT\u03b12-t was detected at a higher level in media from colon, pancreatic, and prostate cancer cell lines than corresponding normal epithelial cells as well as in the plasma of CRC patients as compared to healthy controls. RKO cells treated with MAT\u03b12-t activated focal adhesion kinase (FAK), an important kinase for cancer cell evasion of apoptosis. Conversely, treatment with MAT\u03b12 neutralizing antibody inhibited FAK and induced apoptosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CRC cells secrete both MAT\u03b12 within EVs and free MAT\u03b12-t. EV-MAT\u03b12 can be internalized and act as a transcription factor to lower hepatocytes\u2019 MAT1A, the major defense against CRLM, while promoting CRC oncogenicity. Freely released MAT\u03b12-t acts as a ligand in an autocrine fashion to activate FAK, which is essential for CRC survival. Taken together, secreted MAT\u03b12 plays an essential role in promoting CRLM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03599-x","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:05:30Z","timestamp":1764677130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel role of secreted methionine adenosyltransferase \u03b12 in colorectal liver metastases"],"prefix":"10.1186","volume":"45","author":[{"given":"Monica","family":"Justo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngyi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Floris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Chandla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Dagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Posadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouad","family":"Edderkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pandol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lauda","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly C.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"3","key":"3599_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3599_CR2","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3599_CR3","first-page":"618","volume":"22","author":"K Zhou","year":"2025","unstructured":"Zhou K, Yang C, Li Y. Multi-omics in colorectal cancer liver metastasis: applications and research advances. Cancer Biol Med. 2025;22(6):618\u201338.","journal-title":"Cancer Biol Med"},{"issue":"10","key":"3599_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","volume":"11","author":"J Martin","year":"2020","unstructured":"Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow HK, et al. Colorectal liver metastases: current management and future perspectives. World J Clin Oncol. 2020;11(10):761\u2013808.","journal-title":"World J Clin Oncol"},{"issue":"5","key":"3599_CR5","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/SLA.0000000000000786","volume":"261","author":"S Dueland","year":"2015","unstructured":"Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, et al. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer? Ann Surg. 2015;261(5):956\u201360.","journal-title":"Ann Surg"},{"issue":"1","key":"3599_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12885-024-12162-4","volume":"24","author":"Y Tian","year":"2024","unstructured":"Tian Y, Wang Y, Wen N, Wang S, Li B, Liu G. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis. BMC Cancer. 2024;24(1):426.","journal-title":"BMC Cancer"},{"issue":"8","key":"3599_CR7","doi-asserted-by":"publisher","first-page":"9559","DOI":"10.1002\/cam4.5732","volume":"12","author":"YM Su","year":"2023","unstructured":"Su YM, Liu W, Yan XL, Wang LJ, Liu M, Wang HW, et al. Five-year survival post hepatectomy for colorectal liver metastases in a real-world Chinese cohort: recurrence patterns and prediction for potential cure. Cancer Med. 2023;12(8):9559\u201369.","journal-title":"Cancer Med"},{"issue":"4","key":"3599_CR8","first-page":"e183","volume":"15","author":"J Lemke","year":"2016","unstructured":"Lemke J, Cammerer G, Ganser J, Scheele J, Xu P, Sander S, et al. Survival and prognostic factors of colorectal liver metastases after surgical and nonsurgical treatment. Clin Colorectal Cancer. 2016;15(4):e183\u201392.","journal-title":"Clin Colorectal Cancer"},{"issue":"4","key":"3599_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1152\/physrev.00047.2011","volume":"92","author":"SC Lu","year":"2012","unstructured":"Lu SC, Mato JM. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012;92(4):1515\u201342.","journal-title":"Physiol Rev"},{"issue":"31","key":"3599_CR10","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.3748\/wjg.v25.i31.4300","volume":"25","author":"B Murray","year":"2019","unstructured":"Murray B, Barbier-Torres L, Fan W, Mato JM, Lu SC. Methionine adenosyltransferases in liver cancer. World J Gastroenterol. 2019;25(31):4300\u201319.","journal-title":"World J Gastroenterol"},{"issue":"39","key":"3599_CR11","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1038\/s41388-021-01980-6","volume":"40","author":"L Lu","year":"2021","unstructured":"Lu L, Zhang J, Fan W, Li Y, Wang J, Li TWH, et al. Deregulated 14-3-3zeta and methionine adenosyltransferase alpha1 interplay promotes liver cancer tumorigenesis in mice and humans. Oncogene. 2021;40(39):5866\u201379.","journal-title":"Oncogene"},{"issue":"2","key":"3599_CR12","doi-asserted-by":"publisher","first-page":"G184","DOI":"10.1152\/ajpgi.2001.280.2.G184","volume":"280","author":"H Yang","year":"2001","unstructured":"Yang H, Huang ZZ, Zeng Z, Chen C, Selby RR, Lu SC. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. Am J Physiol Gastrointest Liver Physiol. 2001;280(2):G184\u201390.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"3599_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/j.gastro.2007.03.114","volume":"133","author":"H Chen","year":"2007","unstructured":"Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, et al. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology. 2007;133(1):207\u201318.","journal-title":"Gastroenterology"},{"key":"3599_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1471-2407-14-196","volume":"14","author":"X Wang","year":"2014","unstructured":"Wang X, Guo X, Yu W, Li C, Gui Y, Cai Z. Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis. BMC Cancer. 2014;14:196.","journal-title":"BMC Cancer"},{"issue":"35","key":"3599_CR15","doi-asserted-by":"publisher","first-page":"37706","DOI":"10.18632\/oncotarget.5342","volume":"6","author":"ML Tomasi","year":"2015","unstructured":"Tomasi ML, Ryoo M, Ramani K, Tomasi I, Giordano P, Mato JM, et al. <article-title update=\"added\">Methionine adenosyltransferase \u03b12 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells. Oncotarget. 2015;6(35):37706\u201323.","journal-title":"Oncotarget"},{"issue":"2","key":"3599_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1535370217740860","volume":"243","author":"LY Maldonado","year":"2018","unstructured":"Maldonado LY, Arsene D, Mato JM, Lu SC. Methionine adenosyltransferases in cancers: mechanisms of dysregulation and implications for therapy. Exp Biol Med (Maywood). 2018;243(2):107\u201317.","journal-title":"Exp Biol Med (Maywood)"},{"key":"3599_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051342","author":"KA Secker","year":"2020","unstructured":"Secker KA, Bloechl B, Keppeler H, Duerr-Stoerzer S, Schmid H, Schneidawind D, et al. MAT2A as key regulator and therapeutic target in MLLr leukemogenesis. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12051342.","journal-title":"Cancers (Basel)"},{"key":"3599_CR18","doi-asserted-by":"crossref","unstructured":"Chu PY, Wu HJ, Wang SM, Chen PM, Tang FY, Chiang EI. MAT2A localization and its independently prognostic relevance in breast cancer patients. Int J Mol Sci. 2021;22(10)5382-96","DOI":"10.3390\/ijms22105382"},{"issue":"3","key":"3599_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jhep.2023.11.022","volume":"80","author":"W Fan","year":"2024","unstructured":"Fan W, Cao D, Yang B, Wang J, Li X, Kitka D, et al. Hepatic prohibitin 1 and methionine adenosyltransferase alpha1 defend against primary and secondary liver cancer metastasis. J Hepatol. 2024;80(3):443\u201353.","journal-title":"J Hepatol"},{"issue":"2","key":"3599_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103111","volume":"5","author":"HY Kim","year":"2024","unstructured":"Kim HY, Lee W, Liu X, Jang H, Sakane S, Carvalho-Gontijo Weber R, et al. Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress. STAR Protoc. 2024;5(2):103111.","journal-title":"STAR Protoc"},{"issue":"7","key":"3599_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13059-014-0412-4","volume":"15","author":"R Worsley Hunt","year":"2014","unstructured":"Worsley Hunt R, Wasserman WW. Non-targeted transcription factors motifs are a systemic component of ChIP-seq datasets. Genome Biol. 2014;15(7):412.","journal-title":"Genome Biol"},{"issue":"3","key":"3599_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/bbrc.1998.8965","volume":"248","author":"Z Mao","year":"1998","unstructured":"Mao Z, Liu S, Cai J, Huang ZZ, Lu SC. Cloning and functional characterization of the 5\u2019-flanking region of human methionine adenosyltransferase 2A gene. Biochem Biophys Res Commun. 1998;248(3):479\u201384.","journal-title":"Biochem Biophys Res Commun"},{"key":"3599_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/bj3460475","volume":"346","author":"Z Zeng","year":"2000","unstructured":"Zeng Z, Huang ZZ, Chen C, Yang H, Mao Z, Lu SC. Cloning and functional characterization of the 5\u2019-flanking region of human methionine adenosyltransferase 1A gene. Biochem J. 2000;346:475\u201382.","journal-title":"Biochem J"},{"key":"3599_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2025.1612186","volume":"31","author":"JM Ott","year":"2025","unstructured":"Ott JM, Gassenmaier V, Bitzer M, Schurch CM, Heitmann JS, Hagelstein I. B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment. Pathol Oncol Res. 2025;31:1612186.","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"3599_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.livres.2017.07.002","volume":"1","author":"K Ramani","year":"2017","unstructured":"Ramani K, Lu SC. Methionine adenosyltransferases in liver health and diseases. Liver Res. 2017;1(2):103\u201311.","journal-title":"Liver Res"},{"issue":"1","key":"3599_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","volume":"12","author":"X Tan","year":"2023","unstructured":"Tan X, Yan Y, Song B, Zhu S, Mei Q, Wu K. Focal adhesion kinase: from biological functions to therapeutic strategies. Exp Hematol Oncol. 2023;12(1):83.","journal-title":"Exp Hematol Oncol"},{"key":"3599_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051153","author":"W Zhang","year":"2021","unstructured":"Zhang W, Lin Y. The mechanism of asparagine endopeptidase in the progression of malignant tumors: a review. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051153.","journal-title":"Cells"},{"issue":"11","key":"3599_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/15384047.2020.1824989","volume":"21","author":"RE Perez","year":"2020","unstructured":"Perez RE, Calhoun S, Shim D, Levenson VV, Duan L, Maki CG. Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biol Ther. 2020;21(11):1033\u201340.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"3599_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70119","volume":"6","author":"W Xu","year":"2025","unstructured":"Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J. Liver metastasis in cancer: molecular mechanisms and management. MedComm. 2025;6(3):e70119.","journal-title":"MedComm"},{"issue":"1","key":"3599_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00922-2","volume":"7","author":"H Zhou","year":"2022","unstructured":"Zhou H, Liu Z, Wang Y, Wen X, Amador EH, Yuan L, et al. Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduct Target Ther. 2022;7(1):70.","journal-title":"Signal Transduct Target Ther"},{"key":"3599_CR31","doi-asserted-by":"crossref","unstructured":"Andryszkiewicz W, Misiag P, Karwowska A, Resler Z, Wojno A, Kulbacka J et al. Cancer metastases to the liver: mechanisms of tumor cell colonization. Pharmaceuticals (Basel). 2024;17(9).","DOI":"10.3390\/ph17091251"},{"issue":"7","key":"3599_CR32","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang Z, Kim SY, Tu W, Kim J, Xu A, Yang YM, et al. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. Cell Metab. 2023;35(7):1209\u2013e2613.","journal-title":"Cell Metab"},{"issue":"12","key":"3599_CR33","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.yexcr.2013.04.005","volume":"319","author":"ML Tomasi","year":"2013","unstructured":"Tomasi ML, Ryoo M, Skay A, Tomasi I, Giordano P, Mato JM, et al. Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer. Exp Cell Res. 2013;319(12):1902\u201311.","journal-title":"Exp Cell Res"},{"key":"3599_CR34","doi-asserted-by":"publisher","first-page":"989999","DOI":"10.3389\/fphar.2022.989999","volume":"13","author":"G Yu","year":"2022","unstructured":"Yu G, Xu M, Zhou L, Zheng K, Zhu X, Sui J, et al. High expression of phosphorylated focal adhesion kinase predicts a poor prognosis in human colorectal cancer. Front Pharmacol. 2022;13:989999.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3599_CR35","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1053\/jhep.2002.32538","volume":"35","author":"C Pa\u00f1eda","year":"2002","unstructured":"Pa\u00f1eda C, Gorospe I, Herrera B, Nakamura T, Fabregat I, Varela-Nieto I. Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation. Hepatology. 2002;35(6):1381\u201391.","journal-title":"Hepatology"},{"issue":"1","key":"3599_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-025-03334-6","volume":"44","author":"M Morillo-Huesca","year":"2025","unstructured":"Morillo-Huesca M, I GL-C, Conesa-Bakkali R, Tome M, Watts C, Huertas P, et al. Radiotherapy resistance driven by asparagine endopeptidase through ATR pathway modulation in breast cancer. J Exp Clin Cancer Res. 2025;44(1):74.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"3599_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4251\/wjgo.v10.i10.290","volume":"10","author":"KY Jeong","year":"2018","unstructured":"Jeong KY. Inhibiting focal adhesion kinase: a potential target for enhancing therapeutic efficacy in colorectal cancer therapy. World J Gastrointest Oncol. 2018;10(10):290\u20132.","journal-title":"World J Gastrointest Oncol"},{"issue":"11","key":"3599_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104189","volume":"29","author":"FE Pulous","year":"2024","unstructured":"Pulous FE, Steurer B, Pun FW, Zhang M, Ren F, Zhavoronkov A. MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer. Drug Discov Today. 2024;29(11):104189.","journal-title":"Drug Discov Today"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03599-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:25:07Z","timestamp":1767709507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03599-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03599-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}